Agniuadenta - Company finances
|
EUR
|
2022
From: 2022-07-14
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 11,640 | 47,770 | 95,929 | 95,819 |
| Profit before tax | 8,329 | 19,126 | 48,714 | 32,538 |
| Net profit | 8,329 | 18,163 | 46,497 | 31,182 |
| Equity | 8,429 | 26,592 | 64,339 | 75,522 |
| Liabilities | 1,905 | 2,592 | 5,630 | 10,418 |
| Non-current assets | 0 | 0 | 0 | 20,125 |
| Current assets | 10,334 | 29,184 | 69,969 | 65,815 |
| Total assets | 10,334 | 29,184 | 69,969 | 85,940 |
|
Taxes paid
|
||||
| STI taxes | - | 1,101 | 1,175 | 3,259 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +310.4% | +100.8% | -0.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 80.6% | 62.2% | 66.5% | 36.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.8% | 68.3% | 72.3% | 41.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 71.6% | 38.0% | 48.5% | 32.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 71.6% | 40.0% | 50.8% | 34.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 47,770 | 95,929 | 95,819 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Agniuadenta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-07-19 | 2023-07-20 | 189.59 |
| 2023-07-07 | 2023-07-11 | 141.37 |
| 2022-09-01 | 2022-09-30 | 50.95 |
Agniuadenta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-18 | 2025-11-18 | 18.01 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Agniuadenta, MB (company code 306115877) is a small partnership operating in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €95.8K and net profit of €31.2K, with a profit margin of 32.5%. Revenue was broadly unchanged year on year, at -0.1% versus 2024, after rising strongly over the longer term from €47.8K in 2023 to €95.9K in 2024 and €95.8K in 2025. Net profit followed a similar pattern, increasing from €18.2K in 2023 to €46.5K in 2024 before easing to €31.2K in 2025. At year-end 2025, total assets stood at €85.9K, equity at €75.5K and liabilities at €10.4K. The equity ratio was 87.9%, debt-to-equity was 0.14, asset turnover was 1.11x, ROE was 41.3% and ROA was 36.3%. Revenue and profit per employee were €95.8K and €31.2K respectively, indicating strong productivity.